Today: 22 December 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Company Overview and Background Acrivon Therapeutics is a Boston-area biotech (NASDAQ: ACRV) founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicine stockanalysis.com. The company’s name “Acrivon” is derived from “accurate” or “precision,” reflecting its core
3 November 2025
 ·  ·  ·  ·  · 
IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

Company Overview & Business Segments IDEXX Laboratories facility in Markham, Canada (one of the company’s global offices). IDEXX Laboratories, Inc. is a veterinary diagnostics and life sciences company that develops, manufactures, and sells products and services for animal health and
3 November 2025
 ·  ·  ·  ·  · 
ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

Sources: Financial data from Yahoo Finance/Refinitiv reuters.com reuters.com and company filings; GlobeNewswire press release globenewswire.com globenewswire.com; Reuters news report reuters.com; Bernama (Malaysia) interview with CEO bernama.com bernama.com; Stock analysis sites and SEC filings for market cap and float details finviz.com
3 November 2025
 ·  ·  ·  ·  · 
Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

Current Price & Recent Performance Berkshire Hathaway’s Class B stock (NYSE: BRK-B) trades around $477–$480 as of early November 2025 stockinvest.us. The share price has eased off about 5% since mid-October, when it briefly crossed the $500 mark before pulling back
3 November 2025
 ·  ·  ·  ·  ·  · 
Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Business Overview and Market Position Micron Technology, Inc. is a leading semiconductor manufacturer specializing in memory and data storage chips. Its product portfolio includes dynamic random access memory (DRAM) chips – used in PCs, servers, and smartphones – and NAND
3 November 2025
 ·  ·  ·  ·  · 
1 … 82 83 84 85 86 … 232
Go toTop